Tag: Immunotherapy clinical trials
New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy
The U.S. Food and Drug Administration (FDA) recently approved a new drug called Jemperli (dostarlimab-gxly) for certain adult patients with endometrial cancer. This drug, developed by British pharmaceutical company GSK, is designed for individuals...